Sorrento Therapeutics (SRNE) Competitors $0.0080 +0.00 (+14.29%) As of 10/20/2025 03:53 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SRNE vs. LSB, PHXM, IMCC, KALA, ADXN, ERNA, XBIO, BFRI, SNPX, and INABShould you be buying Sorrento Therapeutics stock or one of its competitors? The main competitors of Sorrento Therapeutics include LakeShore Biopharma (LSB), PHAXIAM Therapeutics (PHXM), IM Cannabis (IMCC), KALA BIO (KALA), Addex Therapeutics (ADXN), Ernexa Therapeutics (ERNA), Xenetic Biosciences (XBIO), Biofrontera (BFRI), Synaptogenix (SNPX), and IN8bio (INAB). These companies are all part of the "pharmaceutical products" industry. Sorrento Therapeutics vs. Its Competitors LakeShore Biopharma PHAXIAM Therapeutics IM Cannabis KALA BIO Addex Therapeutics Ernexa Therapeutics Xenetic Biosciences Biofrontera Synaptogenix IN8bio LakeShore Biopharma (NASDAQ:LSB) and Sorrento Therapeutics (NASDAQ:SRNE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment. Which has more risk and volatility, LSB or SRNE? LakeShore Biopharma has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500. Comparatively, Sorrento Therapeutics has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Which has preferable valuation and earnings, LSB or SRNE? LakeShore Biopharma has higher revenue and earnings than Sorrento Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLakeShore Biopharma$85.67M0.13-$13.93MN/AN/ASorrento Therapeutics$60.32M0.07-$572.84MN/AN/A Does the media refer more to LSB or SRNE? In the previous week, LakeShore Biopharma had 1 more articles in the media than Sorrento Therapeutics. MarketBeat recorded 1 mentions for LakeShore Biopharma and 0 mentions for Sorrento Therapeutics. LakeShore Biopharma's average media sentiment score of 0.00 equaled Sorrento Therapeutics'average media sentiment score. Company Overall Sentiment LakeShore Biopharma Neutral Sorrento Therapeutics Neutral Do institutionals & insiders have more ownership in LSB or SRNE? 52.6% of LakeShore Biopharma shares are owned by institutional investors. Comparatively, 0.0% of Sorrento Therapeutics shares are owned by institutional investors. 2.6% of Sorrento Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is LSB or SRNE more profitable? Company Net Margins Return on Equity Return on Assets LakeShore BiopharmaN/A N/A N/A Sorrento Therapeutics N/A N/A N/A SummaryLakeShore Biopharma beats Sorrento Therapeutics on 5 of the 7 factors compared between the two stocks. Get Sorrento Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRNE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNE vs. The Competition Export to ExcelMetricSorrento TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.86M$347.81M$6.13B$10.54BDividend YieldN/AN/A5.72%4.85%P/E RatioN/AN/A29.4827.34Price / Sales0.07502.23551.26220.24Price / CashN/A22.4425.8230.35Price / BookN/A3.7712.366.69Net Income-$572.84M-$127.22M$3.32B$276.46M7 Day PerformanceN/A-1.99%1.83%-0.08%1 Month PerformanceN/A7.82%8.83%3.93%1 Year PerformanceN/A4.80%62.18%33.89% Sorrento Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNESorrento Therapeutics1.0095 of 5 stars$0.01+14.3%N/A+158.1%$3.86M$60.32M0.00800Gap DownLSBLakeShore BiopharmaN/A$0.53-33.0%N/A-83.2%$11.01M$85.67M0.00773High Trading VolumePHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58MN/A0.0049IMCCIM Cannabis0.0938 of 5 stars$1.95+1.0%N/A-3.4%$10.13M$39.44M-3.61340Negative NewsKALAKALA BIO4.0984 of 5 stars$1.49+4.2%$20.38+1,267.4%-81.7%$10.04M$3.89M-0.2230Short Interest ↑ADXNAddex Therapeutics1.0762 of 5 stars$8.52-9.7%N/A-13.9%$10M$460K-25.0630Gap DownERNAErnexa Therapeutics0.2935 of 5 stars$1.25-3.5%N/A-91.8%$9.93M$580K-0.1510Short Interest ↑Gap UpXBIOXenetic Biosciences1.432 of 5 stars$5.37-15.2%N/A+7.3%$9.76M$2.50M-2.694Short Interest ↓Gap UpBFRIBiofrontera1.7757 of 5 stars$0.94-1.9%$2.75+191.9%+17.8%$9.73M$37.32M-0.4270SNPXSynaptogenixN/A$6.89-2.8%N/A+123.3%$9.58MN/A-0.684Gap DownHigh Trading VolumeINABIN8bio3.53 of 5 stars$2.17+3.3%$92.00+4,139.6%-73.6%$9.53MN/A-0.2420 Related Companies and Tools Related Companies LakeShore Biopharma Competitors PHAXIAM Therapeutics Competitors IM Cannabis Competitors KALA BIO Competitors Addex Therapeutics Competitors Ernexa Therapeutics Competitors Xenetic Biosciences Competitors Biofrontera Competitors Synaptogenix Competitors IN8bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRNE) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRNE Stock Alerts